Document:

I.Q. BIOMETRIX, INC.

                                 2001 STOCK PLAN

                          NOTICE OF STOCK OPTION GRANT
                          ----------------------------

        You have been granted an option to purchase Common Stock of IQ Biometrix
(the "Company") as follows:

<TABLE>
<CAPTION>
<S>                                       <C>
        Board Approval Date:              April 2, 2003

        Date of Grant:                    April 2, 2003

        Exercise Price per Share:         $1.10

        Total Number of Shares Granted:   200,000

        Total Exercise Price:             $210,000

        Type of Option:                   Incentive Stock Option

        Expiration Date:                  April 1, 2008

        Vesting Commencement Date:        April 2, 2003

        Vesting/Exercise Schedule:        So long as your employment or consulting
                                          relationship with the Company continues, the Shares
                                          underlying this Option shall vest and become
                                          exercisable in accordance with the following
                                          schedule: 100,000 shares vested immediately, 25,000
                                          of the Shares subject to the Option shall vest and
                                          become exercisable on the 3 month anniversary of
                                          the Vesting Commencement Date and 25,000 of the
                                          total number of Shares subject to the Option shall
                                          vest and become exercisable each quarter thereafter.

<PAGE>

        Termination Period:               This Option may be exercised for 45 days after
                                          termination of employment or consulting
                                          relationship except as set out in Section 5 of the
                                          Stock Option Agreement (but in no event later than
                                          the Expiration Date).  Optionee is responsible for
                                          keeping track of these exercise periods following
                                          termination for any reason of his or her service
                                          relationship with the Company.  The Company will
                                          not provide further notice of such periods.

        Transferability:                  This Option may not be transferred.
</TABLE>

        By your signature and the signature of the Company's representative
below, you and the Company agree that this option is granted under and governed
by the terms and conditions of the IQ Biometrix, Inc. 2001 Stock Plan and the
Stock Option Agreement, both of which are attached and made a part of this
document.

        In addition, you agree and acknowledge that your rights to any Shares
underlying the Option will be earned only as you provide services to the Company
over time, that the grant of the Option is not as consideration for services you
rendered to the Company prior to your Vesting Commencement Date, and that
nothing in this Notice or the attached documents confers upon you any right to
continue your employment or consulting relationship with the Company for any
period of time, nor does it interfere in any way with your right or the
Company's right to terminate that relationship at any time, for any reason, with
or without cause.

                                   I.Q. Biometrix, Inc.

/s/ William Scigliano              By: /s/ Michael Walsh
--------------------------             --------------------------
William Scigliano                      Michael P Walsh, Chief Financial Officer

                                      -2-
<PAGE>

                               IQ BIOMETRIX, INC.

                                 2001 STOCK PLAN

                             STOCK OPTION AGREEMENT
                             ----------------------

        1. Grant of Option. IQ Biometrix, Inc., a California corporation (the
"Company"), hereby grants to William Scigliano ("Optionee"), an option (the
"Option") to purchase the total number of shares of Common Stock (the "Shares")
set forth in the Notice of Stock Option Grant (the "Notice"), at the exercise
price per Share set forth in the Notice (the "Exercise Price") subject to the
terms, definitions and provisions of the IQ Biometrix, Inc. 2001 Stock Plan (the
"Plan") adopted by the Company, which is incorporated in this Agreement by
reference. Unless otherwise defined in this Agreement, the terms used in this
Agreement shall have the meanings defined in the Plan.

        2. Designation of Option. This Option is intended to be an Incentive
Stock Option as defined in Section 422 of the Code only to the extent so
designated in the Notice, and to the extent it is not so designated or to the
extent the Option does not qualify as an Incentive Stock Option, it is intended
to be a Nonstatutory Stock Option.

        Notwithstanding the above, if designated as an Incentive Stock Option,
in the event that the Shares subject to this Option (and all other Incentive
Stock Options granted to Optionee by the Company or any Parent or Subsidiary,
including under other plans of the Company) that first become exercisable in any
calendar year have an aggregate fair market value (determined for each Share as
of the date of grant of the option covering such Share) in excess of $100,000,
the Shares in excess of $100,000 shall be treated as subject to a Nonstatutory
Stock Option, in accordance with Section 5(c) of the Plan.

        3. Exercise of Option. This Option shall be exercisable during its term
in accordance with the Vesting/Exercise Schedule set out in the Notice and with
the provisions of Section 10 of the Plan as follows:

               (a) Right to Exercise.

                      (i) This Option may not be exercised for a fraction of a
share.

                      (ii) In the event of Optionee's death, disability or other
termination of employment, the exercisability of the Option is governed by
Section 5 below, subject to the limitations contained in this Section 3.

                      (iii) In no event may this Option be exercised after the
Expiration Date of the Option as set forth in the Notice.

<PAGE>

               (b) Method of Exercise.

                      (i) This Option shall be exercisable by execution and
delivery of the Exercise Notice and Restricted Stock Purchase Agreement attached
hereto as Exhibit A (the "Exercise Agreement") or of any other form of written
notice approved for such purpose by the Company which shall state Optionee's
election to exercise the Option, the number of Shares in respect of which the
Option is being exercised, and such other representations and agreements as to
the holder's investment intent with respect to such Shares as may be required by
the Company pursuant to the provisions of the Plan. Such written notice shall be
signed by Optionee and shall be delivered to the Company by such means as are
determined by the Plan Administrator in its discretion to constitute adequate
delivery. The written notice shall be accompanied by payment of the Exercise
Price. This Option shall be deemed to be exercised upon receipt by the Company
of such written notice accompanied by the Exercise Price.

                      (ii) As a condition to the exercise of this Option and as
further set forth in Section 12 of the Plan, Optionee agrees to make adequate
provision for federal, state or other tax withholding obligations, if any, which
arise upon the vesting or exercise of the Option, or disposition of Shares,
whether by withholding, direct payment to the Company, or otherwise.

                      (iii) The Company is not obligated, and will have no
liability for failure, to issue or deliver any Shares upon exercise of the
Option unless such issuance or delivery would comply with the Applicable Laws,
with such compliance determined by the Company in consultation with its legal
counsel. This Option may not be exercised until such time as the Plan has been
approved by the stockholders of the Company, or if the issuance of such Shares
upon such exercise or the method of payment of consideration for such shares
would constitute a violation of any applicable federal or state securities or
other law or regulation, including any rule under Part 221 of Title 12 of the
Code of Federal Regulations as promulgated by the Federal Reserve Board. As a
condition to the exercise of this Option, the Company may require Optionee to
make any representation and warranty to the Company as may be required by the
Applicable Laws. Assuming such compliance, for income tax purposes the Shares
shall be considered transferred to Optionee on the date on which the Option is
exercised with respect to such Shares.

        4. Method of Payment. Payment of the Exercise Price shall be by any of
the following, or a combination of the following, at the election of Optionee:

               (a) cash or check;

               (b) prior to the date, if any, upon which the Common Stock
becomes a Listed Security, by surrender of other shares of Common Stock of the
Company that have an aggregate Fair Market Value on the date of surrender equal
to the Exercise Price of the Shares as to which the Option is being exercised.
In the case of shares acquired directly or indirectly from the Company, such
shares must have been owned by Optionee for more than six (6) months on the date
of surrender (or such other period of time as is necessary to avoid the
Company's incurring adverse accounting charges); or

                                      -2-
<PAGE>

               (c) following the date, if any, upon which the Common Stock is a
Listed Security, delivery of a properly executed exercise notice together with
irrevocable instructions to a broker approved by the Company to deliver promptly
to the Company the amount of sale or loan proceeds required to pay the exercise
price.

        5. Termination of Relationship. Following the date of termination of
Optionee's Continuous Service Status for any reason (the "Termination Date"),
Optionee may exercise the Option only as set forth in the Notice and this
Section 5. To the extent that Optionee is not entitled to exercise this Option
as of the Termination Date, or if Optionee does not exercise this Option within
the Termination Period set forth in the Notice or the termination periods set
forth below, the Option shall terminate in its entirety. In no event, may any
Option be exercised after the Expiration Date of the Option as set forth in the
Notice.

               (a) Termination. In the event of termination of Optionee's
Continuous Service Status other than as a result of Optionee's disability or
death, Optionee may, to the extent otherwise so entitled at the date of such
termination (the "Termination Date"), exercise this Option during the
Termination Period set forth in the Notice.

               (b) Other Terminations. In connection with any termination other
than a termination covered by Section 5(a), Optionee may exercise the Option
only as described below:

                      (i) Termination upon Disability of Optionee. In the event
of termination of Optionee's Continuous Service Status as a result of Optionee's
disability, Optionee may, but only within six months from the Termination Date,
exercise this Option to the extent Optionee was entitled to exercise it as of
such Termination Date.

                      (ii) Death of Optionee. In the event of the death of
Optionee (a) during the term of this Option and while an Employee or Consultant
of the Company and having been in Continuous Service Status since the date of
grant of the Option, or (b) within thirty (30) days after Optionee's Termination
Date, the Option may be exercised at any time within six months following the
date of death by Optionee's estate or by a person who acquired the right to
exercise the Option by bequest or inheritance, but only to the extent Optionee
was entitled to exercise the Option as of the Termination Date.

        6. Non-Transferability of Option. Except as otherwise set forth in the
Notice, this Option may not be transferred in any manner otherwise than by will
or by the laws of descent or distribution and may be exercised during the
lifetime of Optionee only by him or her. The terms of this Option shall be
binding upon the executors, administrators, heirs, successors and assigns of
Optionee.

        7. Tax Consequences. Below is a brief summary as of the date of this
Option of certain of the federal tax consequences of exercise of this Option and
disposition of the Shares under the laws in effect as of the Date of Grant. THIS
SUMMARY IS INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE.
OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING
OF THE SHARES.

                                      -3-
<PAGE>

               (a) Incentive Stock Option.

                      (i) Tax Treatment upon Exercise and Sale of Shares. If
this Option qualifies as an Incentive Stock Option, there will be no regular
federal income tax liability upon the exercise of the Option, although the
excess, if any, of the fair market value of the Shares on the date of exercise
over the Exercise Price will be treated as an adjustment to the alternative
minimum tax for federal tax purposes and may subject Optionee to the alternative
minimum tax in the year of exercise. If Shares issued upon exercise of an
Incentive Stock Option are held for at least one year after exercise and are
disposed of at least two years after the Option grant date, any gain realized on
disposition of the Shares will also be treated as long-term capital gain for
federal income tax purposes. If Shares issued upon exercise of an Incentive
Stock Option are disposed of within such one-year period or within two years
after the Option grant date, any gain realized on such disposition will be
treated as compensation income (taxable at ordinary income rates) to the extent
of the difference between the Exercise Price and the lesser of (i) the fair
market value of the Shares on the date of exercise, or (ii) the sale price of
the Shares.

                      (ii) Notice of Disqualifying Dispositions. With respect to
any Shares issued upon exercise of an Incentive Stock Option, if Optionee sells
or otherwise disposes of such Shares on or before the later of (i) the date two
years after the Option grant date, or (ii) the date one year after the date of
exercise, Optionee shall immediately notify the Company in writing of such
disposition. Optionee acknowledges and agrees that he or she may be subject to
income tax withholding by the Company on the compensation income recognized by
Optionee from the early disposition by payment in cash or out of the current
earnings paid to Optionee.

               (b) Nonstatutory Stock Option. If this Option does not qualify as
an Incentive Stock Option, there may be a regular federal (and state) income tax
liability upon the exercise of the Option. Optionee will be treated as having
received compensation income (taxable at ordinary income tax rates) equal to the
excess, if any, of the fair market value of the Shares on the date of exercise
over the Exercise Price. If Optionee is an Employee, the Company will be
required to withhold from Optionee's compensation or collect from Optionee and
pay to the applicable taxing authorities an amount equal to a percentage of this
compensation income at the time of exercise. If Shares issued upon exercise of a
Nonstatutory Stock Option are held for at least one year, any gain realized on
disposition of the Shares will be treated as long-term capital gain for federal
income tax purposes.

        8. Lock-Up Agreement. In connection with the initial public offering of
the Company's securities and upon request of the Company or the underwriters
managing any underwritten offering of the Company's securities, Optionee hereby
agrees not to sell, make any short sale of, loan, grant any option for the
purchase of, or otherwise dispose of any securities of the Company however and
whenever acquired (other than those included in the registration) without the
prior written consent of the Company or such underwriters, as the case may be,
for such period of time (not to exceed 180 days) from the effective date of such
registration as may be requested by the Company or such managing underwriters
and to execute an agreement reflecting the foregoing as may be requested by the
underwriters at the time of the public offering.

                                      -4-
<PAGE>

        9. Effect of Agreement. Optionee acknowledges receipt of a copy of the
Plan and represents that he or she is familiar with the terms and provisions
thereof (and has had an opportunity to consult counsel regarding the Option
terms), and hereby accepts this Option and agrees to be bound by its contractual
terms as set forth herein and in the Plan. Optionee hereby agrees to accept as
binding, conclusive and final all decisions and interpretations of the Plan
Administrator regarding any questions relating to the Option. In the event of a
conflict between the terms and provisions of the Plan and the terms and
provisions of the Notice and this Agreement, the Plan terms and provisions shall
prevail. The Option, including the Plan, constitutes the entire agreement
between Optionee and the Company on the subject matter hereof and supersedes all
proposals, written or oral, and all other communications between the parties
relating to such subject matter.

                            [Signature Page Follows]

                                      -5-
<PAGE>

        This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original and all of which together shall constitute one
document.

William Scigliano

_____________________________               By: ___________________________
                                            Name: _________________________
Dated: ______________________               Title: ________________________

                                      -6-
<PAGE>

                                    EXHIBIT A
                                    ---------

                               IQ BIOMETRIX, INC.

                                 2001 STOCK PLAN

             EXERCISE NOTICE AND RESTRICTED STOCK PURCHASE AGREEMENT
             -------------------------------------------------------

        This Agreement ("Agreement") is made as of December 1, 2001, by and
between IQ Biometrix, a Delaware corporation (the "Company"), and William
Scigliano ("Purchaser"). To the extent any capitalized terms used in this
Agreement are not defined, they shall have the meaning ascribed to them in the
2001 Stock Plan Stock Option Agreement.

        1. Exercise of Option. Subject to the terms and conditions hereof,
Purchaser hereby elects to exercise his or her option to purchase
___________shares of the Common Stock (the "Shares") of the Company under and
pursuant to the Company's 2001 Stock Option Plan (the "Plan") and the Stock
Option Agreement granted December 1, 2001 (the "Option Agreement"). The purchase
price for the Shares shall be $0.10 per Share for a total purchase price of
$________. The term "Shares" refers to the purchased Shares and all securities
received in replacement of the Shares or as stock dividends or splits, all
securities received in replacement of the Shares in a recapitalization, merger,
reorganization, exchange or the like, and all new, substituted or additional
securities or other properties to which Purchaser is entitled by reason of
Purchaser's ownership of the Shares.

        2. Time and Place of Exercise. The purchase and sale of the Shares under
this Agreement shall occur at the principal office of the Company simultaneously
with the execution and delivery of this Agreement in accordance with the
provisions of Section 3(b) of the Option Agreement. On such date, the Company
will deliver to Purchaser a certificate representing the Shares to be purchased
by Purchaser (which shall be issued in Purchaser's name) against payment of the
exercise price therefor by Purchaser by (a) check made payable to the Company,
(b) cancellation of indebtedness of the Company to Purchaser, (c) delivery of
shares of the Common Stock of the Company in accordance with Section 4 of the
Option Agreement, or (d) by a combination of the foregoing.

        3. Limitations on Transfer. In addition to any other limitation on
transfer created by applicable securities laws, Purchaser shall not assign,
encumber or dispose of any interest in the Shares except in compliance with the
provisions below and applicable securities laws.

               (a) Right of First Refusal. Before any Shares held by Purchaser
or any transferee of Purchaser (either being sometimes referred to herein as the
"Holder") may be sold or otherwise transferred (including transfer by gift or
operation of law), the Company or its assignee(s) shall have a right of first
refusal to purchase the Shares on the terms and conditions set forth in this
Section 3(a) (the "Right of First Refusal").

<PAGE>

                      (i) Notice of Proposed Transfer. The Holder of the Shares
shall deliver to the Company a written notice (the "Notice") stating: (i) the
Holder's bona fide intention to sell or otherwise transfer such Shares; (ii) the
name of each proposed purchaser or other transferee ("Proposed Transferee");
(iii) the number of Shares to be transferred to each Proposed Transferee; and
(iv) the terms and conditions of each proposed sale or transfer. The Holder
shall offer the Shares at the same price (the "Offered Price") and upon the same
terms (or terms as similar as reasonably possible) to the Company or its
assignee(s).

                      (ii) Exercise of Right of First Refusal. At any time
within thirty (30) days after receipt of the Notice, the Company and/or its
assignee(s) may, by giving written notice to the Holder, elect to purchase all,
but not less than all, of the Shares proposed to be transferred to any one or
more of the Proposed Transferees, at the purchase price determined in accordance
with subsection (iii) below.

                      (iii) Purchase Price. The purchase price ("Purchase
Price") for the Shares purchased by the Company or its assignee(s) under this
Section 3(a) shall be the Offered Price. If the Offered Price includes
consideration other than cash, the cash equivalent value of the non-cash
consideration shall be determined by the Board of Directors of the Company in
good faith.

                      (iv) Payment. Payment of the Purchase Price shall be made,
at the option of the Company or its assignee(s), in cash (by check), by
cancellation of all or a portion of any outstanding indebtedness, or by any
combination thereof within 30 days after receipt of the Notice or in the manner
and at the times set forth in the Notice.

                      (v) Holder's Right to Transfer. If all of the Shares
proposed in the Notice to be transferred to a given Proposed Transferee are not
purchased by the Company and/or its assignee(s) as provided in this Section
3(a), then the Holder may sell or otherwise transfer such Shares to that
Proposed Transferee at the Offered Price or at a higher price, provided that
such sale or other transfer is consummated within 60 days after the date of the
Notice and provided further that any such sale or other transfer is effected in
accordance with any applicable securities laws and the Proposed Transferee
agrees in writing that the provisions of this Section 3 shall continue to apply
to the Shares in the hands of such Proposed Transferee. If the Shares described
in the Notice are not transferred to the Proposed Transferee within such period,
or if the Holder proposes to change the price or other terms to make them more
favorable to the Proposed Transferee, a new Notice shall be given to the
Company, and the Company and/or its assignees shall again be offered the Right
of First Refusal before any Shares held by the Holder may be sold or otherwise
transferred.

                      (vi) Exception for Certain Family Transfers. Anything to
the contrary contained in this Section 3(a) notwithstanding, the transfer of any
or all of the Shares during Purchaser's lifetime or on Purchaser's death by will
or intestacy to Purchaser's Immediate Family or a trust for the benefit of
Purchaser's Immediate Family shall be exempt from the provisions of this Section
3(a). "Immediate Family" as used herein shall mean spouse, lineal descendant or
antecedent, father, mother, brother or sister. In such case, the transferee or
other recipient shall receive and hold the Shares so transferred subject to the
provisions of this Section, and there shall be no further transfer of such
Shares except in accordance with the terms of this Section 3.

                                      -2-
<PAGE>

               (b) Involuntary Transfer.

                      (i) Company's Right to Purchase upon Involuntary Transfer.
In the event, at any time after the date of this Agreement, of any transfer by
operation of law or other involuntary transfer (including death or divorce, but
excluding a transfer to Immediate Family as set forth in Section 3(a)(vi) above)
of all or a portion of the Shares by the record holder thereof, the Company
shall have an option to purchase all of the Shares transferred at the greater of
the purchase price paid by Purchaser pursuant to this Agreement or the Fair
Market Value of the Shares on the date of transfer. Upon such a transfer, the
person acquiring the Shares shall promptly notify the Secretary of the Company
of such transfer. The right to purchase such Shares shall be provided to the
Company for a period of thirty (30) days following receipt by the Company of
written notice by the person acquiring the Shares.

                      (ii) Price for Involuntary Transfer. With respect to any
stock to be transferred pursuant to Section 3(b)(i), the price per Share shall
be a price set by the Board of Directors of the Company that will reflect the
current value of the stock in terms of present earnings and future prospects of
the Company. The Company shall notify Purchaser or his or her executor of the
price so determined within thirty (30) days after receipt by it of written
notice of the transfer or proposed transfer of Shares. However, if the Purchaser
does not agree with the valuation as determined by the Board of Directors of the
Company, the Purchaser shall be entitled to have the valuation determined by an
independent appraiser to be mutually agreed upon by the Company and the
Purchaser and whose fees shall be borne equally by the Company and the
Purchaser.

               (c) Assignment. The right of the Company to purchase any part of
the Shares may be assigned in whole or in part to any shareholder or
shareholders of the Company or other persons or organizations.

               (e) Restrictions Binding on Transferees. All transferees of
Shares or any interest therein will receive and hold such Shares or interest
subject to the provisions of this Agreement. Any sale or transfer of the
Company's Shares shall be void unless the provisions of this Agreement are
satisfied.

               (f) Termination of Rights. The right of first refusal granted the
Company by Section 3(a) above and the option to repurchase the Shares in the
event of an involuntary transfer granted the Company by Section 3(b) above shall
terminate upon the first sale of Common Stock of the Company to the general
public pursuant to a registration statement filed with and declared effective by
the Securities and Exchange Commission under the Securities Act of 1933, as
amended (the "Securities Act"). Upon termination of the right of first refusal
described in Section 3(a) above, a new certificate or certificates representing
the Shares not repurchased shall be issued, on request, without the legend
referred to in Section 5(a)(ii) herein and delivered to Purchaser.

                                      -3-
<PAGE>

        4. Investment and Taxation Representations. In connection with the
purchase of the Shares, Purchaser represents to the Company the following:

               (a) Purchaser is aware of the Company's business affairs and
financial condition and has acquired sufficient information about the Company to
reach an informed and knowledgeable decision to acquire the Shares. Purchaser is
purchasing these securities for investment for his or her own account only and
not with a view to, or for resale in connection with, any "distribution" thereof
within the meaning of the Securities Act or under any applicable provision of
state law. Purchaser does not have any present intention to transfer the Shares
to any person or entity.

               (b) Purchaser understands that the Shares have not been
registered under the Securities Act by reason of a specific exemption therefrom,
which exemption depends upon, among other things, the bona fide nature of
Purchaser's investment intent as expressed herein.

               (c) Purchaser further acknowledges and understands that the
securities must be held indefinitely unless they are subsequently registered
under the Securities Act or an exemption from such registration is available.
Purchaser further acknowledges and understands that the Company is under no
obligation to register the securities. Purchaser understands that the
certificate(s) evidencing the securities will be imprinted with a legend which
prohibits the transfer of the securities unless they are registered or such
registration is not required in the opinion of counsel for the Company.

               (d) Purchaser is familiar with the provisions of Rules 144 and
701, each promulgated under the Securities Act, which, in substance, permit
limited public resale of "restricted securities" acquired, directly or
indirectly, from the issuer of the securities (or from an affiliate of such
issuer), in a non-public offering subject to the satisfaction of certain
conditions. Purchaser understands that the Company provides no assurances as to
whether he or she will be able to resell any or all of the Shares pursuant to
Rule 144 or Rule 701, which rules require, among other things, that the Company
be subject to the reporting requirements of the Securities Exchange Act of 1934,
as amended, that resales of securities take place only after the holder of the
Shares has held the Shares for certain specified time periods, and under certain
circumstances, that resales of securities be limited in volume and take place
only pursuant to brokered transactions. Notwithstanding this paragraph (d),
Purchaser acknowledges and agrees to the restrictions set forth in paragraph (e)
below.

               (e) Purchaser further understands that in the event all of the
applicable requirements of Rule 144 or 701 are not satisfied, registration under
the Securities Act, compliance with Regulation A, or some other registration
exemption will be required; and that, notwithstanding the fact that Rules 144
and 701 are not exclusive, the Staff of the Securities and Exchange Commission
has expressed its opinion that persons proposing to sell private placement
securities other than in a registered offering and otherwise than pursuant to
Rule 144 or 701 will have a substantial burden of proof in establishing that an
exemption from registration is available for such offers or sales, and that such
persons and their respective brokers who participate in such transactions do so
at their own risk.

                                      -4-
<PAGE>

               (f) Purchaser understands that Purchaser may suffer adverse tax
consequences as a result of Purchaser's purchase or disposition of the Shares.
Purchaser represents that Purchaser has consulted any tax consultants Purchaser
deems advisable in connection with the purchase or disposition of the Shares and
that Purchaser is not relying on the Company for any tax advice.

        5. Restrictive Legends and Stop-Transfer Orders.

               (a) Legends. The certificate or certificates representing the
Shares shall bear the following legends (as well as any legends required by
applicable state and federal corporate and securities laws):

                      (i)    THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT
                             BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
                             AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH
                             A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
                             DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION
                             MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION
                             STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL
                             FOR THE COMPANY THAT SUCH REGISTRATION IS NOT
                             REQUIRED UNDER THE SECURITIES ACT OF 1933.

                      (ii)   THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE
                             TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN
                             AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER,
                             A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF
                             THE COMPANY.

                      (iii)  IT IS UNLAWFUL TO CONSUMMATE A SALE OR TRANSFER OF
                             THIS SECURITY, OR ANY INTEREST THEREIN, OR TO
                             RECEIVE ANY CONSIDERATION THEREFOR, WITHOUT THE
                             PRIOR WRITTEN CONSENT OF THE COMMISSIONER OF
                             CORPORATIONS OF THE STATE OF CALIFORNIA, EXCEPT AS
                             PERMITTED IN THE COMMISSIONER'S RULES.

                (b) Stop-Transfer Notices. Purchaser agrees that, in order to
ensure compliance with the restrictions referred to herein, the Company may
issue appropriate "stop transfer" instructions to its transfer agent, if any,
and that, if the Company transfers its own securities, it may make appropriate
notations to the same effect in its own records.

                                      -5-
<PAGE>

               (c) Refusal to Transfer. The Company shall not be required (i) to
transfer on its books any Shares that have been sold or otherwise transferred in
violation of any of the provisions of this Agreement or (ii) to treat as owner
of such Shares or to accord the right to vote or pay dividends to any purchaser
or other transferee to whom such Shares shall have been so transferred.

        6. No Employment Rights. Nothing in this Agreement shall affect in any
manner whatsoever the right or power of the Company, or a parent or subsidiary
of the Company, to terminate Purchaser's employment or consulting relationship,
for any reason, with or without cause.

        7. Lock-Up Agreement. In connection with the initial public offering of
the Company's securities and upon request of the Company or the underwriters
managing any underwritten offering of the Company's securities, Purchaser agrees
not to sell, make any short sale of, loan, grant any option for the purchase of,
or otherwise dispose of any securities of the Company however or whenever
acquired (other than those included in the registration) without the prior
written consent of the Company or such underwriters, as the case may be, for
such period of time (not to exceed 180 days) from the effective date of such
registration as may be requested by the Company or such managing underwriters
and to execute an agreement reflecting the foregoing as may be requested by the
underwriters at the time of the public offering.

        8. Miscellaneous.

               (a) Governing Law. This Agreement and all acts and transactions
pursuant hereto and the rights and obligations of the parties hereto shall be
governed, construed and interpreted in accordance with the laws of the State of
California, without giving effect to principles of conflicts of law.

               (b) Entire Agreement; Enforcement of Rights. This Agreement sets
forth the entire agreement and understanding of the parties relating to the
subject matter herein and merges all prior discussions between them. No
modification of or amendment to this Agreement, nor any waiver of any rights
under this Agreement, shall be effective unless in writing signed by the parties
to this Agreement. The failure by either party to enforce any rights under this
Agreement shall not be construed as a waiver of any rights of such party.

               (c) Severability. If one or more provisions of this Agreement are
held to be unenforceable under applicable law, the parties agree to renegotiate
such provision in good faith. In the event that the parties cannot reach a
mutually agreeable and enforceable replacement for such provision, then (i) such
provision shall be excluded from this Agreement, (ii) the balance of the
Agreement shall be interpreted as if such provision were so excluded and (iii)
the balance of the Agreement shall be enforceable in accordance with its terms.

               (d) Construction. This Agreement is the result of negotiations
between and has been reviewed by each of the parties hereto and their respective
counsel, if any; accordingly, this Agreement shall be deemed to be the product
of all of the parties hereto, and no ambiguity shall be construed in favor of or
against any one of the parties hereto.

                                      -6-
<PAGE>

               (e) Notices. Any notice required or permitted by this Agreement
shall be in writing and shall be deemed sufficient when delivered personally or
sent by telegram or fax or forty-eight (48) hours after being deposited in the
U.S. mail, as certified or registered mail, with postage prepaid, and addressed
to the party to be notified at such party's address as set forth below or as
subsequently modified by written notice.

               (f) Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original and all of which
together shall constitute one instrument.

               (g) Successors and Assigns. The rights and benefits of this
Agreement shall inure to the benefit of, and be enforceable by the Company's
successors and assigns. The rights and obligations of Purchaser under this
Agreement may only be assigned with the prior written consent of the Company.

                (h) California Corporate Securities Law. THE SALE OF THE
SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH
THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF
THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION
THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES
IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA
CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY
CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.

                            [Signature Page Follows]

                                      -7-

<PAGE>

        The parties have executed this Exercise Notice and Restricted Stock
Purchase Agreement as of the date first set forth above.

                                   COMPANY:

                                   IQ Biometrix, Inc.

                                   By: _______________________________
                                   Name: _____________________________
                                   Title: ____________________________

                                   PURCHASER:

                                   William Scigliano

                                   ___________________________________
                                   (Signature)

                                   Address: __________________________

                                            __________________________

I, ______________________, spouse of __________________ have read and hereby
approve the foregoing Agreement. In consideration of the Company's granting my
spouse the right to purchase the Shares as set forth in the Agreement, I hereby
agree to be irrevocably bound by the Agreement and further agree that any
community property or other such interest shall hereby by similarly bound by the
Agreement. I hereby appoint my spouse as my attorney-in-fact with respect to any
amendment or exercise of any rights under the Agreement.

                                   ___________________________________

                                   Spouse of _________________________

                                      -8-
<PAGE>

           Do not include this page if relying upon Section 25102(o):
           ----------------------------------------------------------

              STATE OF CALIFORNIA - CALIFORNIA ADMINISTRATIVE CODE
              ----------------------------------------------------
         Title 10. Investment - Chapter 3. Commissioner of Corporations

     260.141.11:  Restriction on Transfer.

     (a) The issuer of any security upon which a restriction on transfer has
been imposed pursuant to Sections 260.102.6, 260.141.10 or 260.534 shall cause a
copy of this section to be delivered to each issuee or transferee of such
security at the time the certificate evidencing the security is delivered to the
issuee or transferee.

     (b) It is unlawful for the holder of any such security to consummate a sale
or transfer of such security, or any interest therein, without the prior written
consent of the Commissioner (until this condition is removed pursuant to Section
260.141.12 of these rules), except:

         (1)  to the issuer;
         (2) pursuant to the order or process of any court;
         (3) to any person described in Subdivision (i) of Section 25102 of the
     Code or Section 260.105.14 of these rules;
         (4) to the transferor's ancestors, descendants or spouse, or any
     custodian or trustee for the account of the transferor or the transferor's
     ancestors, descendants, or spouse; or to a transferee by a trustee or
     custodian for the account of the transferee or the transferee's ancestors,
     descendants or spouse;
         (5) to holders of securities of the same class of the same issuer;
         (6) by way of gift or donation inter vivos or on death;
         (7) by or through a broker-dealer licensed under the Code (either
     acting as such or as a finder) to a resident of a foreign state, territory
     or country who is neither domiciled in this state to the knowledge of the
     broker-dealer, nor actually present in this state if the sale of such
     securities is not in violation of any securities law of the foreign state,
     territory or country concerned;
         (8) to a broker-dealer licensed under the Code in a principal
     transaction, or as an underwriter or member of an underwriting syndicate or
     selling group;
         (9) if the interest sold or transferred is a pledge or other lien given
     by the purchaser to the seller upon a sale of the security for which the
     Commissioner's written consent is obtained or under this rule not required;
         (10) by way of a sale qualified under Sections 25111, 25112, 25113 or
     25121 of the Code, of the securities to be transferred, provided that no
     order under Section 25140 or Subdivision (a) of Section 25143 is in effect
     with respect to such qualification;
         (11) by a corporation to a wholly owned subsidiary of such corporation,
     or by a wholly owned subsidiary of a corporation to such corporation;
         (12) by way of an exchange qualified under Section 25111, 25112 or
     25113 of the Code, provided that no order under Section 25140 or
     Subdivision (a) of Section 25143 is in effect with respect to such
     qualification;
         (13) between residents of foreign states, territories or countries who
     are neither domiciled nor actually present in this state;
         (14) to the State Controller pursuant to the Unclaimed Property Law or
     to the administrator of the unclaimed property law of another state;
         (15) by the State Controller pursuant to the Unclaimed Property Law or
     by the administrator of the unclaimed property law of another state if, in
     either such case, such person (i) discloses to potential purchasers at the
     sale that transfer of the securities is restricted under this rule, (ii)
     delivers to each purchaser a copy of this rule, and (iii) advises the
     Commissioner of the name of each purchaser;
         (16) by a trustee to a successor trustee when such transfer does not
     involve a change in the beneficial ownership of the securities; or
         (17) by way of an offer and sale of outstanding securities in an issuer
     transaction that is subject to the qualification requirement of Section
     25110 of the Code but exempt from that qualification requirement by
     subdivision (f) of Section 25102;

provided that any such transfer is on the condition that any certificate
evidencing the security issued to such transferee shall contain the legend
required by this section.

<PAGE>

     (c) The certificates representing all such securities subject to such a
restriction on transfer, whether upon initial issuance or upon any transfer
thereof, shall bear on their face a legend, prominently stamped or printed
thereon in capital letters of not less than 10-point size, reading as follows:

         "IT IS UNLAWFUL TO CONSUMMATE A SALE OR TRANSFER OF THIS SECURITY, OR
ANY INTEREST THEREIN, OR TO RECEIVE ANY CONSIDERATION THEREFOR, WITHOUT THE
PRIOR WRITTEN CONSENT OF THE COMMISSIONER OF CORPORATIONS OF THE STATE OF
CALIFORNIA, EXCEPT AS PERMITTED IN THE COMMISSIONER'S RULES."

<PAGE>

                                     RECEIPT
                                     -------

         The undersigned hereby acknowledges receipt of Certificate No. _____
for __________ shares of Common Stock of IQ Biometrix, Inc.

Dated:  _______________                     _________________________________
                                            William Scigliano

<PAGE>

                                     RECEIPT
                                     -------

         IQ Biometrix, Inc. (the "Company") hereby acknowledges receipt of
(check as applicable):

   ______   A check in the amount of $____________

   ______   The cancellation of indebtedness in the amount of $____________

   ______   Certificate No. _____ representing __________ shares of the

            Company's Common Stock with a fair market value of $___________

given by ________________________ as consideration for Certificate No. _____ for
_________ shares of Common Stock of the Company.

Dated:  ______________
                                            IQ Biometrix, Inc.

                                            By: ___________________________

                                            Name: _________________________
                                                       (print)

                                            Title: ________________________STOCK OPTION AGREEMENT

         THIS STOCK OPTION AGREEMENT (the "Agreement") is made effective March
1, 2004 between IQ BIOMETRIX, INC., a Delaware corporation (the "Company"), and
the consultant to the Company whose name appears on the signature page hereof
under the caption "OPTIONEE" ("Optionee").

                                    RECITALS:

         A. The Company has retained Optionee as its CEO to provide the
appropriate duties to the job in conducting of Company's business (such services
are referred to hereinafter as the "Services").

         B. In order to provide incentives for the furnishing of Services by
Optionee, the Company has determined to grant to Optionee the right to acquire
certain shares of the Company's common stock with par value of $0.01 per share
(hereinafter called "Common Stock"), all as provided more fully hereinafter, all
subject to the terms, provisions and conditions of this Agreement.

                                   WITNESSETH:

         1. GRANT OF STOCK OPTION; PURCHASE PRICE; VESTING; EXPIRATION DATE.
Subject to any vesting schedule attached hereto, the Company hereby grants to
Optionee the right to purchase 200,000 shares of Common Stock at a per-share
purchase price of $1.50, pursuant to the terms, provisions and conditions of
this Agreement (the shares of Common Stock pursuant to which Optionee shall
acquire the right to purchase are referred to hereinafter as the "Option
Shares"). If no vesting schedule is attached hereto or if an attached vesting
schedule does not provide for specifics regarding the vesting of the option
granted hereby, the option granted hereby shall become vested and exercisable
with respect to all of Option Shares immediately upon the execution and delivery
of this Agreement by the Company. The option granted hereunder shall expire with
respect to any particular Option Shares Five (5) years after such option becomes
vested with respect to such shares. In the event of Optionee's death prior to
the otherwise applicable expiration date, the option created by this Agreement
(to the extent then vested) shall be exercisable for one year after Optionee's
death by the legal representative of the estate of Optionee or the person(s) who
acquires the rights of Optionee hereunder by bequest or inheritance as a result
of the death of Optionee.

         2. EXERCISE. Subject to the limitations contained herein, Optionee may
exercise the option created pursuant to this Agreement with respect to vested
Option Shares at any time after it becomes effective and such Option Shares
vest. If Optionee or Optionee's successor fails to exercise the option created
under this Agreement with respect to any vested Option Shares on or before the
expiration date provided for herein with respect to such Option Shares, the
option with respect to such vested Option Shares shall expire on such expiration
date and be of no further force and effect. The option to purchase granted
hereunder shall be exercised by giving written notice to the Company in
compliance with this Agreement. Such notice shall state the number of vested
Option Shares with respect to which the option is being exercised and shall
specify a date which shall not be less than fifteen (15) nor more than thirty
(30) days after the date of such notice, as the date on which such Option Shares
will be taken up and payment made therefor in cash, certified or bank cashier's
check, or the equivalent, at the principal office of the Company. If any law or
regulation requires the Company to take any action with respect to the vested
Option Shares specified in such notice, then the date of the delivery of such
Option Shares against payment therefor shall be extended for the period
necessary to take such action. In the event of any failure to take up and pay
for the number of vested Option Shares specified in such notice on the date set
forth therein, as the same may be extended as provided above, such exercise of
this option may be terminated by the Company with respect to such number of
vested Option Shares not taken and paid for. Each exercise of an option pursuant
to this Agreement shall be deemed to be an exercise with respect to the Option
Shares having the earliest expiration date.

<PAGE>

         3. ADJUSTMENTS.

         (a) If the outstanding shares of the Common Stock shall be subdivided
into a greater number of shares or a dividend in Common Stock shall be paid in
respect of Common Stock, the per share purchase price of the Option Shares in
effect immediately prior to such subdivision or at the record date of such
dividend shall simultaneously with the effectiveness of such subdivision or
immediately after the record date of such dividend be proportionately reduced.
If the outstanding shares of Common Stock shall be combined into a smaller
number of shares, the per share purchase price of the Option Shares in effect
immediately prior to such combination shall, simultaneously with the
effectiveness of such combination, be proportionately increased. When any
adjustment is required to be made in the per share purchase price of the Option
Shares, the number of Option Shares purchasable upon the exercise of the Option
shall be changed to the number determined by dividing (i) an amount equal to the
number of shares issuable upon the exercise of the Option immediately prior to
such adjustment, multiplied by the per share purchase price of the Option Shares
in effect immediately prior to such adjustment, by (ii) the per share purchase
price of the Option Shares in effect immediately after such adjustment.

         (b) If there shall occur any capital reorganization or reclassification
of the Common Stock (other than a change in par value or a subdivision or
combination as provided for in subsection (a) immediately above), or any
consolidation or merger of the Company with or into another corporation, or a
transfer of all or substantially all of the assets of the Company, or the
payment of a liquidating distribution then, as part of any such reorganization,
reclassification, consolidation, merger, sale or liquidating distribution,
lawful provision shall be made so that Optionee shall have the right thereafter
to receive upon the exercise hereof (to the extent, if any, still exercisable)
the kind and amount of shares of stock or other securities or property which
Optionee would have been entitled to receive if, immediately prior to any such
reorganization, reclassification, consolidation, merger, sale or liquidating
distribution, as the case may be, Optionee had held the number of shares of
Common Stock which were then purchasable upon the exercise of the Option. In any
such case, appropriate adjustment (as reasonably determined by the Board of
Directors of the Company) shall be made in the application of the provisions set
forth herein with respect to the rights and interests thereafter of Optionee
such that the provisions set forth in this Section 3 (including provisions with
respect to adjustment of the per share purchase price of the Option Shares)
shall thereafter be applicable, as nearly as is reasonably practicable, in
relation to any shares of stock or other securities or property thereafter
deliverable upon the exercise of the Option.

         (c) for purposes of this Section, a change in control shall be deemed
to have occurred upon (i) the event of a merger, consolidation, share exchange
or reorganization, unless the stockholders of the Company, immediately before
such merger, consolidation, share exchange or reorganization, own, directly or
indirectly immediately following such merger, consolidation, share exchange or
reorganization, more than fifty percent (50%) of the combined voting power of
the outstanding voting securities of the corporation that is the successor in
such merger, consolidation, share exchange or reorganization in substantially
the same proportion as their ownership of the voting securities immediately
before such merger, consolidation, share exchange or reorganization or (ii) an
agreement for the sale or other disposition of all or substantially all of the
assets of IQB. In the event of a change of control, the Company shall give
notice to the Registered Holder to such effect at least 30 days prior to the
proposed date of the change in control. Notwithstanding anything else contained
herein, in the event of a change in control, 100% of the then unvested shares
shall immediately become vested shares upon the giving of the Company's notice
pursuant to the preceding sentence.

                                       2
<PAGE>

         4. SHARES RESERVED. The Company will, at all times during the term of
this Agreement, reserve and keep available such number of its common shares as
will be sufficient to satisfy the requirements of this Agreement and will pay
all fees and expenses necessarily incurred by the Company in connection with the
issuance of such shares.

         5. RESTRICTION ON ISSUANCE OF SHARES; LEGENDS. The Company will not be
obligated to sell any Option Shares hereunder unless the Option Shares are at
the time exempt from registration under the Securities Act of 1933, as amended,
and applicable state securities laws. Optionee shall make such investment
representations to the Company and shall consent to the imposition of such
legends on the stock certificates as are necessary, in the opinion of the
Company's counsel, to secure to the Company an appropriate exemption from
applicable securities laws.

         6. SUCCESSORS. This Agreement will be binding upon any successor of the
Company.

         7. NO RIGHTS AS SHAREHOLDER. Optionee shall have no rights as a
shareholder by reason of this Agreement and shall have only those rights
expressly conferred by this Agreement.

         8. NONTRANSFERABILITY. This option will not be transferable other than
by will or the laws of descent or distribution or pursuant to a qualified
domestic relations order as defined in the Internal Revenue Code of 1986, as
amended, or Title I of the Employee Retirement Income Security Act of 1974, as
amended, or the rules thereunder, and during the lifetime of Optionee the option
may be exercised only by Optionee. More particularly (but without limiting the
generality of the foregoing), the option may not be assigned, transferred,
pledged or hypothecated in any way, may not be assignable by operation of law,
and may not be subject to execution, attachment or similar process. Any
attempted assignment, transfer, pledge, hypothecation or other disposition of
the option contrary to the provisions hereof, and the levy of any execution,
attachment or similar process upon the option, will be null and void and without
effect.

         9. WITHHOLDING TAXES. Upon exercise of any portion of this option and
notice from the Company to Optionee, Optionee shall pay to the Company the
amount of withholding income tax required to be withheld by the Company from
compensation to Optionee and in turn paid by the Company to the U.S. Internal
Revenue Service.

         10. NOTICES. All notices, requests, demands and other communications
hereunder shall be in writing and shall be deemed to have been given if
delivered or mailed, first class, with postage prepaid, to:

                  if to the Company, addressed to:

                           IQ Biometrix, Inc.
                           39111 Paseo Padre Parkway
                           Suite 304
                           Fremont CA 94538

                  if to Optionee, addressed to the address for notice set forth
                  beneath Optionee's signature below;

or to such other address for notice as either party shall hereafter notify the
other party in writing, from time to time.

                                       3
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement
effective as of the date first set forth above.

                                   "COMPANY"

                                   IQ BIOMETRIX, INC.

                                   By: /s/ Michael Walsh
                                       -------------------------------
                                       Michael Walsh, CFO

                                   "OPTIONEE"

                                   /s/ William Scigliano
                                   -----------------------------------
                                   William Scigliano

                                   Address for Optionee:

                                   The Crone Law Group
                                   201 Mission Street, Suite 1930
                                   San Francisco California 94105
                                   Facsimile: 415.495.8900

                                       4
<PAGE>

         VESTING SCHEDULE

         "(i) this Option shall become vested and exercisable with respect to
1/24th of the Option Shares 30 days after the date of grant (the "Vesting
Commencement Date"),

         (ii) an additional 1/24th of the Option Shares shall vest each month
thereafter on the same day of the month as the Vesting Commencement Date,
subject to Optionee continuing to provide services on such dates.

         (iii) Subject to any other term of this Agreement, this Option shall be
exercisable for forty-five (45) days after Optionee ceases to be provide
Services to the Company. In no event may Optionee exercise this Option after the
Term/Expiration Date as provided above. Optionee is responsible for keeping
track of these exercise periods following termination for any reason of his or
her service relationship with the Company. The Company will not provide further
notice of such periods.

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]